Vector VestAdvertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade, grantg2, Big_Money_Upward, Peacefulwendy
Search This Board:
Last Post: 1/26/2015 7:30:20 PM - Followers: 291 - Board type: Free - Posts Today: 0

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact:
Media Contact:

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  


NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods. (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Statement of Changes in Beneficial Ownership (4) 12/31/2014 05:06:14 PM
ONVO News: Statement of Changes in Beneficial Ownership (4) 12/31/2014 05:05:11 PM
ONVO News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 12/30/2014 05:17:53 PM
ONVO News: Current Report Filing (8-k) 12/30/2014 05:14:41 PM
ONVO News: Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 12/15/2014 08:05:00 AM
#7461  Sticky Note CNBC Fast Money/Smart Money Segment: Peacefulwendy 12/12/14 11:35:52 AM
#7214  Sticky Note Article today on CNN money shorty355 11/04/14 10:44:51 AM
#6278  Sticky Note ONVO news: "Organovo Reports Positive Results from a rayank 06/26/14 10:25:47 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#7695   You really don't understand what is happening? ONVO dshade 01/26/15 07:30:20 PM
#7694   Good run up into the close - at Alvie 01/26/15 03:59:57 PM
#7693   Put a time frame on it. .25 move RallyTheMarket 01/26/15 12:22:02 PM
#7692   Thanks for the timeline info. rumper 01/26/15 11:23:37 AM
#7691   ka-boom - First 7.50, then 12... ElCollector 01/26/15 10:57:34 AM
#7690   If there are sales for the quarter it analytic 01/25/15 09:46:33 PM
#7689   exVive3Ds Only Live 6 weeks, Plenty_of_Time_has_Passed rumper 01/25/15 10:35:03 AM
#7688   WEF Davos 2015 Hub Culture Interview with Dr scratchy 01/24/15 10:06:56 AM
#7687   I'm still seeing "N/A" for the share price lnong 01/23/15 10:42:45 PM
#7686   Long and stronger going into news. dshade 01/23/15 12:04:36 PM
#7685   lol gl! Theo 01/22/15 10:17:55 AM
#7684   No need to apologize. My handle is Windbag1014 01/22/15 10:14:01 AM
#7683   "I bought this with the idea that it Theo 01/22/15 10:10:34 AM
#7682   Convince me otherwise, please. Windbag1014 01/22/15 09:52:53 AM
#7681   One more week of trading for Jan 2015, rumper 01/22/15 06:28:25 AM
#7680   The Etrade chart I was using was off. RallyTheMarket 01/21/15 04:14:48 PM
#7679   So you missed my $2, $3, $4, $5 dshade 01/21/15 04:04:52 PM
#7678   It's the age old good cop bad cop RallyTheMarket 01/21/15 03:46:13 PM
#7677   This only further proves the notion that once RallyTheMarket 01/21/15 03:41:58 PM
#7676   Or you could have used my post on RallyTheMarket 01/21/15 03:34:41 PM
#7675   Paying attention to human nature and historical patterns dshade 01/21/15 11:17:49 AM
#7674   So you ignore the short but hound the dshade 01/21/15 11:13:11 AM
#7673   Learn to read a chart and you won't RallyTheMarket 01/21/15 11:12:01 AM
#7672   Now you are learning why he posts when dshade 01/21/15 11:09:09 AM
#7671   I choose to ignore him because we all RallyTheMarket 01/21/15 10:57:27 AM
#7670   We moved because we bounced off key support RallyTheMarket 01/21/15 10:56:17 AM
#7669   Funny how you ignore the short accusing rayank dshade 01/21/15 10:56:03 AM
#7668   Again open your eyes. Did we not move dshade 01/21/15 10:52:40 AM
#7667   Then please cease making baseless claims of short RallyTheMarket 01/21/15 10:47:01 AM
#7666   Please cease trying to predict what I do dshade 01/21/15 10:43:39 AM
#7665   So what's your time table on this news RallyTheMarket 01/21/15 10:07:21 AM
#7664   FORTUNATELY, investing in ONVO is smart and makes dshade 01/20/15 09:36:03 PM
#7663   Unfortunately, Gaps Are Usually Filled, 5.50isTheGap rumper 01/20/15 12:10:35 PM
#7662   Or not listen to such petty banter and dshade 01/20/15 11:35:39 AM
#7661   Oddly enough it's proven to be very true. RandolRocketman 01/20/15 11:22:01 AM
#7660   Or just learn to read a chart and RallyTheMarket 01/20/15 11:14:32 AM
#7659   Always signal to start buying when shorty shows. dshade 01/20/15 10:17:57 AM
#7658   Pumping? Link back from my post adeezl. I rayank 01/19/15 02:11:15 PM
#7657   Yes you just write biased articles on stocks adeezl 01/19/15 10:05:57 AM
#7656   Keep pumping, this company is hilarious and I adeezl 01/19/15 10:03:56 AM
#7655   Organovo Holdings, Inc. (ONVO) rayank 01/16/15 07:05:54 PM
#7654   Can someone please fill me in on what lnong 01/16/15 05:52:03 PM
#7653   Last 20 mins Fri trading: The OK Corral maverick_1 01/16/15 04:24:23 PM
#7652   Been looking into doing some options as well, stockmama22 01/16/15 11:08:10 AM
#7650   Almost at my add point. Bet news on dshade 01/15/15 12:03:42 PM
#7649   Good bet. Took similar action yesterday as well. dshade 01/15/15 07:40:32 AM
#7648   Just bought 10k of ONVO Feb options - ElCollector 01/14/15 03:30:57 PM
#7647   Is that tons of big buys end of RallyTheMarket 01/12/15 04:06:48 PM
#7646   I don't need to ask myself that question RallyTheMarket 01/12/15 12:14:18 PM
#7645   At the exact same time someone unloaded this rayank 01/12/15 10:40:46 AM